Home / Street Sector / Eye Catching Active Stocks: Intra-Cellular Therapies (NASDAQ:ITCI), Digital Ally (NASDAQ:DGLY)

Eye Catching Active Stocks: Intra-Cellular Therapies (NASDAQ:ITCI), Digital Ally (NASDAQ:DGLY)

Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) [Trend Analysis] runs in leading trade, it moving up 17.50% to traded at $14.10. The firm has price volatility of 8.41% for a week and 5.91% for a month. Intra-Cellular Therapies Inc. (ITCI) reported that a loss of $30.3 million in its third quarter. The New York-based firm stated it had a loss of 70 cents per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share. The biopharmaceutical firm posted income of $4,000 in the period. Narrow down four to firm performance, its weekly performance was 19.59% and monthly performance was -2.49%. The stock price of ITCI is moving up from its 20 days moving average with 11.34% and isolated negatively from 50 days moving average with -44.82%.

Digital Ally Inc. (NASDAQ:DGLY) [Trend Analysis] luring active investment momentum, shares a loss -2.00% to $4.90. Digital Ally, Inc. (NASDAQ: DGLY) reported that its operating results for the third quarter and first nine months of 2016. An investor conference call is planned for 11:15 a.m. EST on Thursday, November 10, 2016 (see details below) to discuss these operating results and other topics of interest.

“We believe our third quarter 2016 incomes were negatively impacted by the ongoing confusion caused by Taser’s misleading press release regarding our patents,” stated Stanton E. Ross, Chief Executive Officer of Digital Ally, Inc. Additionally, our FirstVU HD sales were hindered by FirstVu HD production issues in 2016. We expect FirstVU HD sales to recover during the remainder of 2016 because we have resolved the FirstVU HD product issues and continue to psurgedcute the patent court cases against our contenders. We believe that the “auto-activation” technology emBOD ied in our VuLink product is becoming a standard requirement for agencies utilizing BOD y-worn cameras. We are encouraged by the progress of litigation instituted against our contenders to protect our patented technology, given the favorable ruling in the Taser International court case we recently reported.” The total volume of 47475 shares held in the session was surprisingly higher than its average volume of 110.90 shares. EPS anticipates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 21.60%, and looking additional price to next year’s EPS is 119.40%. While take a short look on price to sales ratio, that was 1.41 .


About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Check Also

Stocks Luring Investors with Juicy Profitability Figures: Oclaro, Inc. (NASDAQ:OCLR), Teradata Corporation (NYSE:TDC)

Oclaro, Inc. (NASDAQ:OCLR) persists its position slightly strong in context of buying side, while shares …

Leave a Reply

Your email address will not be published. Required fields are marked *